Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway

Fen Tang, Mario Thiego F. Pacheco, Ping Chen, Dan Liang, Wei Li

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Secretogranin III (Scg3) was recently discovered as the first highly diabetic retinopathy-associated angiogenic factor, and its neutralizing antibody alleviated the disease with high efficacy in diabetic mice. Investigation of its molecular mechanisms will facilitate the translation of this novel therapy. Scg3 was reported to induce the phosphorylation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK). Here we characterized the importance of MEK/ERK activation to Scg3 angiogenic activity. Our results showed that MEK inhibitor PD98059 blocked Scg3-induced proliferation of human umbilical vein endothelial cells (HUVECs). This finding was corroborated by PD98059 inhibition of HUVEC migration and tube formation. Furthermore, ERK inhibitor SCH772984 also suppressed Scg3-induced proliferation and migration of HUVECs. Taken together, these findings suggest that MEK-ERK pathway plays an important role in Scg3-induced angiogenesis.

Original languageEnglish (US)
Pages (from-to)781-786
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume495
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Endothelial cells
Human Umbilical Vein Endothelial Cells
Phosphorylation
Angiogenesis Inducing Agents
Diabetic Retinopathy
Neutralizing Antibodies
Cell Movement
Chemical activation
secretogranin III
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one

Keywords

  • Angiogenesis
  • Angiogenic factor
  • ERK
  • MEK
  • Scg3
  • Secretogranin III

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway. / Tang, Fen; Pacheco, Mario Thiego F.; Chen, Ping; Liang, Dan; Li, Wei.

In: Biochemical and Biophysical Research Communications, Vol. 495, No. 1, 01.01.2018, p. 781-786.

Research output: Contribution to journalArticle

Tang, Fen ; Pacheco, Mario Thiego F. ; Chen, Ping ; Liang, Dan ; Li, Wei. / Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway. In: Biochemical and Biophysical Research Communications. 2018 ; Vol. 495, No. 1. pp. 781-786.
@article{87d4c46fa1e4428ba1133500bd391dfe,
title = "Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway",
abstract = "Secretogranin III (Scg3) was recently discovered as the first highly diabetic retinopathy-associated angiogenic factor, and its neutralizing antibody alleviated the disease with high efficacy in diabetic mice. Investigation of its molecular mechanisms will facilitate the translation of this novel therapy. Scg3 was reported to induce the phosphorylation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK). Here we characterized the importance of MEK/ERK activation to Scg3 angiogenic activity. Our results showed that MEK inhibitor PD98059 blocked Scg3-induced proliferation of human umbilical vein endothelial cells (HUVECs). This finding was corroborated by PD98059 inhibition of HUVEC migration and tube formation. Furthermore, ERK inhibitor SCH772984 also suppressed Scg3-induced proliferation and migration of HUVECs. Taken together, these findings suggest that MEK-ERK pathway plays an important role in Scg3-induced angiogenesis.",
keywords = "Angiogenesis, Angiogenic factor, ERK, MEK, Scg3, Secretogranin III",
author = "Fen Tang and Pacheco, {Mario Thiego F.} and Ping Chen and Dan Liang and Wei Li",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2017.11.080",
language = "English (US)",
volume = "495",
pages = "781--786",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway

AU - Tang, Fen

AU - Pacheco, Mario Thiego F.

AU - Chen, Ping

AU - Liang, Dan

AU - Li, Wei

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Secretogranin III (Scg3) was recently discovered as the first highly diabetic retinopathy-associated angiogenic factor, and its neutralizing antibody alleviated the disease with high efficacy in diabetic mice. Investigation of its molecular mechanisms will facilitate the translation of this novel therapy. Scg3 was reported to induce the phosphorylation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK). Here we characterized the importance of MEK/ERK activation to Scg3 angiogenic activity. Our results showed that MEK inhibitor PD98059 blocked Scg3-induced proliferation of human umbilical vein endothelial cells (HUVECs). This finding was corroborated by PD98059 inhibition of HUVEC migration and tube formation. Furthermore, ERK inhibitor SCH772984 also suppressed Scg3-induced proliferation and migration of HUVECs. Taken together, these findings suggest that MEK-ERK pathway plays an important role in Scg3-induced angiogenesis.

AB - Secretogranin III (Scg3) was recently discovered as the first highly diabetic retinopathy-associated angiogenic factor, and its neutralizing antibody alleviated the disease with high efficacy in diabetic mice. Investigation of its molecular mechanisms will facilitate the translation of this novel therapy. Scg3 was reported to induce the phosphorylation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK). Here we characterized the importance of MEK/ERK activation to Scg3 angiogenic activity. Our results showed that MEK inhibitor PD98059 blocked Scg3-induced proliferation of human umbilical vein endothelial cells (HUVECs). This finding was corroborated by PD98059 inhibition of HUVEC migration and tube formation. Furthermore, ERK inhibitor SCH772984 also suppressed Scg3-induced proliferation and migration of HUVECs. Taken together, these findings suggest that MEK-ERK pathway plays an important role in Scg3-induced angiogenesis.

KW - Angiogenesis

KW - Angiogenic factor

KW - ERK

KW - MEK

KW - Scg3

KW - Secretogranin III

UR - http://www.scopus.com/inward/record.url?scp=85034085743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034085743&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2017.11.080

DO - 10.1016/j.bbrc.2017.11.080

M3 - Article

VL - 495

SP - 781

EP - 786

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -